Microbiology of acute bacterial dacryocystitis: a tertiary institutional experience in South Australia.
Humans
Female
Middle Aged
Dacryocystitis
/ microbiology
Male
Eye Infections, Bacterial
/ microbiology
Retrospective Studies
South Australia
/ epidemiology
Acute Disease
Anti-Bacterial Agents
/ therapeutic use
Aged
Tertiary Care Centers
/ statistics & numerical data
Adult
Bacteria
/ isolation & purification
Microbial Sensitivity Tests
Aged, 80 and over
Staphylococcus aureus
Acute dacryocystitis
Antibiotic
Sensitivity
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
26 Jun 2024
26 Jun 2024
Historique:
received:
13
01
2024
accepted:
22
06
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
epublish
Résumé
To provide a comprehensive microbiological profile of bacterial dacryocystitis in South Australia. By identifying the specific microorganism and antibiotic susceptibility, this study intends to aid ophthalmologists in choosing appropriate empirical antibiotic therapies and development of evidence-based clinical guidelines. A retrospective study was conducted at the Royal Adelaide Hospital (RAH) over five years (2018-2023) of patients with acute dacryocystitis. The study included 43 patients, and data encompassed demographic information, clinical presentation, microbiological analysis, management, and outcomes. Patients with chronic dacryocystitis were excluded. Among the 43 patients included in the study (female 28 (65%), mean age: 64 years old), the most common clinical features were pain (74%) and swelling (70%). Organisms were identified in 49% of patients, with the predominant bacteria being Staphylococcus aureus (42%), Streptococcus species (19%), and Escherichia coli (8%). Aggregatibacter species (8%), Morganella morganii (4%), Enterobacter cloaceae (4%), Hafnia alvei (4%), mixed anaerobes (4%), E coliforms (4%) and Pseudomonas aeruginosa (4%) were also identified. The most frequently prescribed empirical antibiotics were amoxicillin-clavulanic acid (50%), flucloxacillin (33%) and cefalexin (18%). The microbiological trends of acute dacryocystitis have largely remained consistent, with a predominance of Gram positive organisms. This is the most recent profile analysis of acute dacryocystitis in South Australia and will help form evidence-based clinical guidelines.
Identifiants
pubmed: 38922457
doi: 10.1007/s10792-024-03236-0
pii: 10.1007/s10792-024-03236-0
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
282Informations de copyright
© 2024. Crown.
Références
Luo B, Li M, Xiang N, Hu W, Liu R, Yan X (2021) The microbiologic spectrum of dacryocystitis. BMC Ophthalmol 21(1):29
doi: 10.1186/s12886-020-01792-4
pubmed: 33430825
pmcid: 7802334
Bharathi MJ, Ramakrishnan R, Maneksha V, Shivakumar C, Nithya V, Mittal S (2008) Comparative bacteriology of acute and chronic dacryocystitis. Eye 22(7):953–960
doi: 10.1038/sj.eye.6702918
pubmed: 17603466
Pinar-Sueiro S, Sota M, Lerchundi TX, Gibelalde A, Berasategui B, Vilar B et al (2012) Dacryocystitis: systematic approach to diagnosis and therapy. Curr Infect Dis Rep 14(2):137–146
doi: 10.1007/s11908-012-0238-8
Ali MJ, Motukupally SR, Joshi SD, Naik MN (2013) The microbiological profile of lacrimal abscess: two decades of experience from a tertiary eye care center. J Ophthalmic Inflamm Infect 3(1):57
doi: 10.1186/1869-5760-3-57
pubmed: 23889760
pmcid: 3750744
Mills DM, Bodman MG, Meyer DR, Morton AD (2007) 3rd, group ADS the microbiologic spectrum of dacryocystitis: a national study of acute versus chronic infection. Ophthalmic Plast Reconstr Surg 23(4):302–6
doi: 10.1097/IOP.0b013e318070d237
pubmed: 17667103
Eslami F, Ghasemi Basir HR, Moradi A, Heidari FS (2018) Microbiological study of dacryocystitis in northwest of Iran. Clin Ophthalmol 12:1859–1864
doi: 10.2147/OPTH.S175463
pubmed: 30310264
pmcid: 6165732
Eshraghi B, Abdi P, Akbari M, Fard MA (2014) Microbiologic spectrum of acute and chronic dacryocystitis. Int J Ophthalmol 7(5):864–867
pubmed: 25349808
pmcid: 4206896
Sainju R, McNab AA, Shreshtha MK, Ruit S (2005) Microbiology of dacryocystitis among adults population in Southern Australia. Nepal Med Coll J 7(1):18–20
pubmed: 16295714
Garg R, Gupta P, Shakya DK, Varandani S, Uchainiya A (2018) Clinico-microbiological profile in dacryocystitis: a prospective observational study. Int J Med Res Rev 6(4):210–217
doi: 10.17511/ijmrr.2018.i04.02
Mauriello JA Jr, Wasserman BA (1996) Acute dacryocystitis: an unusual cause of life-threatening orbital intraconal abscess with frozen globe. Ophthalmic Plast Reconstr Surg 12(4):294–295
doi: 10.1097/00002341-199612000-00013
pubmed: 8944391
Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109(7):309–318
doi: 10.1179/2047773215Y.0000000030
pubmed: 26343252
pmcid: 4768623
Razavi ME, Ansari-Astaneh MR, Farzadnia M, Rahmaniyan H, Moghiman T (2010) Bacteriological evaluation of adult dacryocystitis in Iran. Orbit 29(5):286–290
doi: 10.3109/01676831003664293
pubmed: 20712513
Mendez L, Ferreira J, Caneiras C (2021) Hafnia alvei pneumonia: a rare cause of infection in a patient with COVID-19. Microorganisms 9(11):2369
doi: 10.3390/microorganisms9112369
pubmed: 34835494
pmcid: 8620350
Gunthard H, Pennekamp A (1996) Clinical significance of extraintestinal Hafnia alvei isolates from 61 patients and review of the literature. Clin Infect Dis 22(6):1040–1045
doi: 10.1093/clinids/22.6.1040
pubmed: 8783707
Cahill KV, Burns JA (1993) Management of acute dacryocystitis in adults. Ophthalmic Plast Reconstr Surg 9(1):38–41 (discussion 2)
doi: 10.1097/00002341-199303000-00005
pubmed: 8443113
Briscoe D, Rubowitz A, Assia E (2005) Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis. Orbit 24(1):29–32
doi: 10.1080/01676830590894897
pubmed: 15764113
Kotlus BS, Rodgers IR, Udell IJ (2005) Dacryocystitis caused by community-onset methicillin-resistant Staphylococcus aureus. Ophthalmic Plast Reconstr Surg 21(5):371–375
doi: 10.1097/01.iop.0000175035.22953.71
pubmed: 16234703
Salgado CD, Farr BM, Calfee DP (2003) Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36(2):131–139
doi: 10.1086/345436
pubmed: 12522744
Sun MT, Simon S, Warner M, Chehade M, Selva D (2012) Methicillin-resistant Staphylococus aureus. Ophthalmol 119(8):1719–e1; author reply 20
Dacryocystitis. Melbourne: therapeutic Guidelines; 2019. Available from: https://tgldcdp-tg-org-au.eu1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Antibiotic&topicfile=dacryocystitis&guidelinename=Antibiotic§ionId=toc_d1e47#toc_d1e47 .
Periorbital (preseptal) and orbital (postseptal) cellulitis. Melbourne: therapeutic guidelines; (2019). Available from: https://tgldcdp-tg-org-au.eu1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Antibiotic&topicfile=periorbital-orbital-cellulitis&guidelinename=Antibiotic§ionId=toc_d1e315#toc_d1e315
Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22(1):161–82 (Table of Contents)
doi: 10.1128/CMR.00036-08
pubmed: 19136439
pmcid: 2620637